Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00367601
Status:
COMPLETED
Last Update Posted:
2016-02-11
First Post:
2006-08-21
Brief Title:
Erlotinib Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
Sponsor:
Nasser Hanna MD
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
HOG LUN04-77
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nasser Hanna MD
Lead Sponsor Class:
OTHER
Responsible Party:
Nasser Hanna MD
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Hoosier Cancer Research Network
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoosier Cancer Research Network | OTHER |
| Genentech Inc | INDUSTRY |
| Walther Cancer Institute | OTHER |